nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Ill-defined disorder—Gemcitabine—lung cancer	0.0025	0.0025	CcSEcCtD
Betahistine—Erythema multiforme—Etoposide—lung cancer	0.0025	0.0025	CcSEcCtD
Betahistine—Malaise—Irinotecan—lung cancer	0.00249	0.00249	CcSEcCtD
Betahistine—Flatulence—Cisplatin—lung cancer	0.00247	0.00247	CcSEcCtD
Betahistine—Erythema multiforme—Paclitaxel—lung cancer	0.00245	0.00245	CcSEcCtD
Betahistine—Dyspnoea—Vinorelbine—lung cancer	0.00244	0.00244	CcSEcCtD
Betahistine—Malaise—Gemcitabine—lung cancer	0.00243	0.00243	CcSEcCtD
Betahistine—Hypersensitivity—Vinblastine—lung cancer	0.00243	0.00243	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00243	0.00243	CcSEcCtD
Betahistine—Immune system disorder—Etoposide—lung cancer	0.00239	0.00239	CcSEcCtD
Betahistine—Asthenia—Vinblastine—lung cancer	0.00236	0.00236	CcSEcCtD
Betahistine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00236	0.00236	CcSEcCtD
Betahistine—Fatigue—Vinorelbine—lung cancer	0.00236	0.00236	CcSEcCtD
Betahistine—Hypersensitivity—Topotecan—lung cancer	0.00236	0.00236	CcSEcCtD
Betahistine—Immune system disorder—Paclitaxel—lung cancer	0.00234	0.00234	CcSEcCtD
Betahistine—Ill-defined disorder—Cisplatin—lung cancer	0.00233	0.00233	CcSEcCtD
Betahistine—Discomfort—Irinotecan—lung cancer	0.00233	0.00233	CcSEcCtD
Betahistine—Asthenia—Topotecan—lung cancer	0.0023	0.0023	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.00228	0.00228	CcSEcCtD
Betahistine—Confusional state—Irinotecan—lung cancer	0.00228	0.00228	CcSEcCtD
Betahistine—Asthenia—Erlotinib—lung cancer	0.00227	0.00227	CcSEcCtD
Betahistine—Discomfort—Gemcitabine—lung cancer	0.00227	0.00227	CcSEcCtD
Betahistine—Malaise—Cisplatin—lung cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Pruritus—Topotecan—lung cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Anaphylactic shock—Irinotecan—lung cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Feeling abnormal—Vinorelbine—lung cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Diarrhoea—Vinblastine—lung cancer	0.00225	0.00225	CcSEcCtD
Betahistine—Pruritus—Erlotinib—lung cancer	0.00224	0.00224	CcSEcCtD
Betahistine—Flatulence—Paclitaxel—lung cancer	0.00222	0.00222	CcSEcCtD
Betahistine—Nervous system disorder—Irinotecan—lung cancer	0.00221	0.00221	CcSEcCtD
Betahistine—Anaphylactic shock—Gemcitabine—lung cancer	0.0022	0.0022	CcSEcCtD
Betahistine—Diarrhoea—Topotecan—lung cancer	0.00219	0.00219	CcSEcCtD
Betahistine—Dizziness—Vinblastine—lung cancer	0.00218	0.00218	CcSEcCtD
Betahistine—Convulsion—Cisplatin—lung cancer	0.00218	0.00218	CcSEcCtD
Betahistine—Urticaria—Vinorelbine—lung cancer	0.00217	0.00217	CcSEcCtD
Betahistine—Diarrhoea—Erlotinib—lung cancer	0.00217	0.00217	CcSEcCtD
Betahistine—Nervous system disorder—Gemcitabine—lung cancer	0.00216	0.00216	CcSEcCtD
Betahistine—Skin disorder—Gemcitabine—lung cancer	0.00214	0.00214	CcSEcCtD
Betahistine—Ill-defined disorder—Etoposide—lung cancer	0.00213	0.00213	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00212	0.00212	CcSEcCtD
Betahistine—Dizziness—Topotecan—lung cancer	0.00212	0.00212	CcSEcCtD
Betahistine—Discomfort—Cisplatin—lung cancer	0.00211	0.00211	CcSEcCtD
Betahistine—Vomiting—Vinblastine—lung cancer	0.00209	0.00209	CcSEcCtD
Betahistine—Dizziness—Erlotinib—lung cancer	0.00209	0.00209	CcSEcCtD
Betahistine—Ill-defined disorder—Paclitaxel—lung cancer	0.00209	0.00209	CcSEcCtD
Betahistine—Erythema multiforme—Docetaxel—lung cancer	0.00208	0.00208	CcSEcCtD
Betahistine—Malaise—Etoposide—lung cancer	0.00207	0.00207	CcSEcCtD
Betahistine—Headache—Vinblastine—lung cancer	0.00206	0.00206	CcSEcCtD
Betahistine—Angioedema—Paclitaxel—lung cancer	0.00206	0.00206	CcSEcCtD
Betahistine—Anaphylactic shock—Cisplatin—lung cancer	0.00205	0.00205	CcSEcCtD
Betahistine—Vomiting—Topotecan—lung cancer	0.00203	0.00203	CcSEcCtD
Betahistine—Malaise—Paclitaxel—lung cancer	0.00203	0.00203	CcSEcCtD
Betahistine—Rash—Topotecan—lung cancer	0.00202	0.00202	CcSEcCtD
Betahistine—Hypersensitivity—Vinorelbine—lung cancer	0.00202	0.00202	CcSEcCtD
Betahistine—Dermatitis—Topotecan—lung cancer	0.00202	0.00202	CcSEcCtD
Betahistine—Vomiting—Erlotinib—lung cancer	0.00201	0.00201	CcSEcCtD
Betahistine—Dyspnoea—Irinotecan—lung cancer	0.00201	0.00201	CcSEcCtD
Betahistine—Nervous system disorder—Cisplatin—lung cancer	0.00201	0.00201	CcSEcCtD
Betahistine—Somnolence—Irinotecan—lung cancer	0.00201	0.00201	CcSEcCtD
Betahistine—Headache—Topotecan—lung cancer	0.002	0.002	CcSEcCtD
Betahistine—Tachycardia—Cisplatin—lung cancer	0.002	0.002	CcSEcCtD
Betahistine—Rash—Erlotinib—lung cancer	0.002	0.002	CcSEcCtD
Betahistine—Dermatitis—Erlotinib—lung cancer	0.00199	0.00199	CcSEcCtD
Betahistine—Convulsion—Etoposide—lung cancer	0.00199	0.00199	CcSEcCtD
Betahistine—Skin disorder—Cisplatin—lung cancer	0.00199	0.00199	CcSEcCtD
Betahistine—Dyspepsia—Irinotecan—lung cancer	0.00199	0.00199	CcSEcCtD
Betahistine—Immune system disorder—Docetaxel—lung cancer	0.00198	0.00198	CcSEcCtD
Betahistine—Headache—Erlotinib—lung cancer	0.00198	0.00198	CcSEcCtD
Betahistine—Asthma—Methotrexate—lung cancer	0.00198	0.00198	CcSEcCtD
Betahistine—Asthenia—Vinorelbine—lung cancer	0.00196	0.00196	CcSEcCtD
Betahistine—Dyspnoea—Gemcitabine—lung cancer	0.00196	0.00196	CcSEcCtD
Betahistine—Nausea—Vinblastine—lung cancer	0.00196	0.00196	CcSEcCtD
Betahistine—Somnolence—Gemcitabine—lung cancer	0.00195	0.00195	CcSEcCtD
Betahistine—Convulsion—Paclitaxel—lung cancer	0.00195	0.00195	CcSEcCtD
Betahistine—Gastrointestinal disorder—Irinotecan—lung cancer	0.00195	0.00195	CcSEcCtD
Betahistine—Fatigue—Irinotecan—lung cancer	0.00195	0.00195	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00195	0.00195	CcSEcCtD
Betahistine—Pruritus—Vinorelbine—lung cancer	0.00194	0.00194	CcSEcCtD
Betahistine—Discomfort—Etoposide—lung cancer	0.00194	0.00194	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00191	0.00191	CcSEcCtD
Betahistine—Nausea—Topotecan—lung cancer	0.0019	0.0019	CcSEcCtD
Betahistine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.0019	0.0019	CcSEcCtD
Betahistine—Discomfort—Paclitaxel—lung cancer	0.0019	0.0019	CcSEcCtD
Betahistine—Fatigue—Gemcitabine—lung cancer	0.0019	0.0019	CcSEcCtD
Betahistine—Confusional state—Etoposide—lung cancer	0.00189	0.00189	CcSEcCtD
Betahistine—Nausea—Erlotinib—lung cancer	0.00188	0.00188	CcSEcCtD
Betahistine—Anaphylactic shock—Etoposide—lung cancer	0.00188	0.00188	CcSEcCtD
Betahistine—Diarrhoea—Vinorelbine—lung cancer	0.00187	0.00187	CcSEcCtD
Betahistine—Feeling abnormal—Irinotecan—lung cancer	0.00186	0.00186	CcSEcCtD
Betahistine—Confusional state—Paclitaxel—lung cancer	0.00186	0.00186	CcSEcCtD
Betahistine—Anaphylactic shock—Paclitaxel—lung cancer	0.00184	0.00184	CcSEcCtD
Betahistine—Tachycardia—Etoposide—lung cancer	0.00183	0.00183	CcSEcCtD
Betahistine—Dyspnoea—Cisplatin—lung cancer	0.00183	0.00183	CcSEcCtD
Betahistine—Skin disorder—Etoposide—lung cancer	0.00182	0.00182	CcSEcCtD
Betahistine—Feeling abnormal—Gemcitabine—lung cancer	0.00181	0.00181	CcSEcCtD
Betahistine—Dizziness—Vinorelbine—lung cancer	0.00181	0.00181	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—lung cancer	0.00181	0.00181	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—lung cancer	0.00181	0.00181	CcSEcCtD
Betahistine—Nervous system disorder—Paclitaxel—lung cancer	0.00181	0.00181	CcSEcCtD
Betahistine—Tachycardia—Paclitaxel—lung cancer	0.0018	0.0018	CcSEcCtD
Betahistine—Skin disorder—Paclitaxel—lung cancer	0.00179	0.00179	CcSEcCtD
Betahistine—Gastrointestinal disorder—Cisplatin—lung cancer	0.00177	0.00177	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00175	0.00175	CcSEcCtD
Betahistine—Vomiting—Vinorelbine—lung cancer	0.00174	0.00174	CcSEcCtD
Betahistine—Rash—Vinorelbine—lung cancer	0.00173	0.00173	CcSEcCtD
Betahistine—Dermatitis—Vinorelbine—lung cancer	0.00172	0.00172	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—lung cancer	0.00172	0.00172	CcSEcCtD
Betahistine—Headache—Vinorelbine—lung cancer	0.00171	0.00171	CcSEcCtD
Betahistine—Asthma—Doxorubicin—lung cancer	0.00171	0.00171	CcSEcCtD
Betahistine—Feeling abnormal—Cisplatin—lung cancer	0.00169	0.00169	CcSEcCtD
Betahistine—Dyspnoea—Etoposide—lung cancer	0.00167	0.00167	CcSEcCtD
Betahistine—Somnolence—Etoposide—lung cancer	0.00167	0.00167	CcSEcCtD
Betahistine—Hypersensitivity—Irinotecan—lung cancer	0.00166	0.00166	CcSEcCtD
Betahistine—Convulsion—Docetaxel—lung cancer	0.00166	0.00166	CcSEcCtD
Betahistine—Dyspnoea—Paclitaxel—lung cancer	0.00164	0.00164	CcSEcCtD
Betahistine—Somnolence—Paclitaxel—lung cancer	0.00164	0.00164	CcSEcCtD
Betahistine—Nausea—Vinorelbine—lung cancer	0.00163	0.00163	CcSEcCtD
Betahistine—Gastrointestinal disorder—Etoposide—lung cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Dyspepsia—Paclitaxel—lung cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Asthenia—Irinotecan—lung cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Fatigue—Etoposide—lung cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00159	0.00159	CcSEcCtD
Betahistine—Fatigue—Paclitaxel—lung cancer	0.00159	0.00159	CcSEcCtD
Betahistine—Asthenia—Gemcitabine—lung cancer	0.00158	0.00158	CcSEcCtD
Betahistine—Confusional state—Docetaxel—lung cancer	0.00157	0.00157	CcSEcCtD
Betahistine—Anaphylactic shock—Docetaxel—lung cancer	0.00156	0.00156	CcSEcCtD
Betahistine—Pruritus—Gemcitabine—lung cancer	0.00156	0.00156	CcSEcCtD
Betahistine—Feeling abnormal—Etoposide—lung cancer	0.00155	0.00155	CcSEcCtD
Betahistine—Diarrhoea—Irinotecan—lung cancer	0.00154	0.00154	CcSEcCtD
Betahistine—Nervous system disorder—Docetaxel—lung cancer	0.00153	0.00153	CcSEcCtD
Betahistine—Tachycardia—Docetaxel—lung cancer	0.00152	0.00152	CcSEcCtD
Betahistine—Feeling abnormal—Paclitaxel—lung cancer	0.00152	0.00152	CcSEcCtD
Betahistine—Skin disorder—Docetaxel—lung cancer	0.00152	0.00152	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00151	0.00151	CcSEcCtD
Betahistine—Hypersensitivity—Cisplatin—lung cancer	0.00151	0.00151	CcSEcCtD
Betahistine—Diarrhoea—Gemcitabine—lung cancer	0.0015	0.0015	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—lung cancer	0.0015	0.0015	CcSEcCtD
Betahistine—Dizziness—Irinotecan—lung cancer	0.00149	0.00149	CcSEcCtD
Betahistine—Urticaria—Etoposide—lung cancer	0.00149	0.00149	CcSEcCtD
Betahistine—Asthenia—Cisplatin—lung cancer	0.00147	0.00147	CcSEcCtD
Betahistine—Urticaria—Paclitaxel—lung cancer	0.00146	0.00146	CcSEcCtD
Betahistine—Vomiting—Irinotecan—lung cancer	0.00144	0.00144	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—lung cancer	0.00143	0.00143	CcSEcCtD
Betahistine—Rash—Irinotecan—lung cancer	0.00142	0.00142	CcSEcCtD
Betahistine—Dermatitis—Irinotecan—lung cancer	0.00142	0.00142	CcSEcCtD
Betahistine—Headache—Irinotecan—lung cancer	0.00141	0.00141	CcSEcCtD
Betahistine—Diarrhoea—Cisplatin—lung cancer	0.0014	0.0014	CcSEcCtD
Betahistine—Vomiting—Gemcitabine—lung cancer	0.0014	0.0014	CcSEcCtD
Betahistine—Dyspnoea—Docetaxel—lung cancer	0.00139	0.00139	CcSEcCtD
Betahistine—Somnolence—Docetaxel—lung cancer	0.00139	0.00139	CcSEcCtD
Betahistine—Rash—Gemcitabine—lung cancer	0.00139	0.00139	CcSEcCtD
Betahistine—Dermatitis—Gemcitabine—lung cancer	0.00139	0.00139	CcSEcCtD
Betahistine—Hypersensitivity—Etoposide—lung cancer	0.00138	0.00138	CcSEcCtD
Betahistine—Headache—Gemcitabine—lung cancer	0.00138	0.00138	CcSEcCtD
Betahistine—Dyspepsia—Docetaxel—lung cancer	0.00137	0.00137	CcSEcCtD
Betahistine—Hypersensitivity—Paclitaxel—lung cancer	0.00136	0.00136	CcSEcCtD
Betahistine—Gastrointestinal disorder—Docetaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Betahistine—Asthenia—Etoposide—lung cancer	0.00135	0.00135	CcSEcCtD
Betahistine—Fatigue—Docetaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Betahistine—Nausea—Irinotecan—lung cancer	0.00134	0.00134	CcSEcCtD
Betahistine—Pruritus—Etoposide—lung cancer	0.00133	0.00133	CcSEcCtD
Betahistine—Asthenia—Paclitaxel—lung cancer	0.00132	0.00132	CcSEcCtD
Betahistine—Nausea—Gemcitabine—lung cancer	0.00131	0.00131	CcSEcCtD
Betahistine—Vomiting—Cisplatin—lung cancer	0.0013	0.0013	CcSEcCtD
Betahistine—Pruritus—Paclitaxel—lung cancer	0.0013	0.0013	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—lung cancer	0.0013	0.0013	CcSEcCtD
Betahistine—Rash—Cisplatin—lung cancer	0.00129	0.00129	CcSEcCtD
Betahistine—Dermatitis—Cisplatin—lung cancer	0.00129	0.00129	CcSEcCtD
Betahistine—Feeling abnormal—Docetaxel—lung cancer	0.00129	0.00129	CcSEcCtD
Betahistine—Diarrhoea—Etoposide—lung cancer	0.00128	0.00128	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—lung cancer	0.00128	0.00128	CcSEcCtD
Betahistine—Diarrhoea—Paclitaxel—lung cancer	0.00126	0.00126	CcSEcCtD
Betahistine—Malaise—Methotrexate—lung cancer	0.00124	0.00124	CcSEcCtD
Betahistine—Dizziness—Etoposide—lung cancer	0.00124	0.00124	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—lung cancer	0.00124	0.00124	CcSEcCtD
Betahistine—Dizziness—Paclitaxel—lung cancer	0.00122	0.00122	CcSEcCtD
Betahistine—Nausea—Cisplatin—lung cancer	0.00122	0.00122	CcSEcCtD
Betahistine—Convulsion—Methotrexate—lung cancer	0.00119	0.00119	CcSEcCtD
Betahistine—Vomiting—Etoposide—lung cancer	0.00119	0.00119	CcSEcCtD
Betahistine—Rash—Etoposide—lung cancer	0.00118	0.00118	CcSEcCtD
Betahistine—Dermatitis—Etoposide—lung cancer	0.00118	0.00118	CcSEcCtD
Betahistine—Headache—Etoposide—lung cancer	0.00118	0.00118	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—lung cancer	0.00118	0.00118	CcSEcCtD
Betahistine—Vomiting—Paclitaxel—lung cancer	0.00117	0.00117	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00117	0.00117	CcSEcCtD
Betahistine—Rash—Paclitaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Betahistine—Dermatitis—Paclitaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Betahistine—Discomfort—Methotrexate—lung cancer	0.00116	0.00116	CcSEcCtD
Betahistine—Headache—Paclitaxel—lung cancer	0.00115	0.00115	CcSEcCtD
Betahistine—Hypersensitivity—Docetaxel—lung cancer	0.00115	0.00115	CcSEcCtD
Betahistine—Confusional state—Methotrexate—lung cancer	0.00113	0.00113	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—lung cancer	0.00112	0.00112	CcSEcCtD
Betahistine—Asthenia—Docetaxel—lung cancer	0.00112	0.00112	CcSEcCtD
Betahistine—Nausea—Etoposide—lung cancer	0.00112	0.00112	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—lung cancer	0.00111	0.00111	CcSEcCtD
Betahistine—Pruritus—Docetaxel—lung cancer	0.0011	0.0011	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—lung cancer	0.0011	0.0011	CcSEcCtD
Betahistine—Nausea—Paclitaxel—lung cancer	0.00109	0.00109	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—lung cancer	0.00109	0.00109	CcSEcCtD
Betahistine—Malaise—Doxorubicin—lung cancer	0.00108	0.00108	CcSEcCtD
Betahistine—Diarrhoea—Docetaxel—lung cancer	0.00107	0.00107	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—lung cancer	0.00103	0.00103	CcSEcCtD
Betahistine—Dizziness—Docetaxel—lung cancer	0.00103	0.00103	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00101	0.00101	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—lung cancer	0.001	0.001	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—lung cancer	0.001	0.001	CcSEcCtD
Betahistine—Somnolence—Methotrexate—lung cancer	0.001	0.001	CcSEcCtD
Betahistine—Vomiting—Docetaxel—lung cancer	0.000992	0.000992	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—lung cancer	0.00099	0.00099	CcSEcCtD
Betahistine—Rash—Docetaxel—lung cancer	0.000984	0.000984	CcSEcCtD
Betahistine—Dermatitis—Docetaxel—lung cancer	0.000983	0.000983	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—lung cancer	0.000982	0.000982	CcSEcCtD
Betahistine—Headache—Docetaxel—lung cancer	0.000978	0.000978	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—lung cancer	0.000974	0.000974	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000971	0.000971	CcSEcCtD
Betahistine—Fatigue—Methotrexate—lung cancer	0.00097	0.00097	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—lung cancer	0.000955	0.000955	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—lung cancer	0.00095	0.00095	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—lung cancer	0.000946	0.000946	CcSEcCtD
Betahistine—Nausea—Docetaxel—lung cancer	0.000927	0.000927	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—lung cancer	0.000927	0.000927	CcSEcCtD
Betahistine—Urticaria—Methotrexate—lung cancer	0.000893	0.000893	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—lung cancer	0.000868	0.000868	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—lung cancer	0.000866	0.000866	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—lung cancer	0.000857	0.000857	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000841	0.000841	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—lung cancer	0.00084	0.00084	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—lung cancer	0.000829	0.000829	CcSEcCtD
Betahistine—Asthenia—Methotrexate—lung cancer	0.000807	0.000807	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—lung cancer	0.000803	0.000803	CcSEcCtD
Betahistine—Pruritus—Methotrexate—lung cancer	0.000796	0.000796	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—lung cancer	0.000774	0.000774	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—lung cancer	0.00077	0.00077	CcSEcCtD
Betahistine—Dizziness—Methotrexate—lung cancer	0.000744	0.000744	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—lung cancer	0.000718	0.000718	CcSEcCtD
Betahistine—Vomiting—Methotrexate—lung cancer	0.000715	0.000715	CcSEcCtD
Betahistine—Rash—Methotrexate—lung cancer	0.000709	0.000709	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—lung cancer	0.000708	0.000708	CcSEcCtD
Betahistine—Headache—Methotrexate—lung cancer	0.000705	0.000705	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—lung cancer	0.000699	0.000699	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—lung cancer	0.000689	0.000689	CcSEcCtD
Betahistine—Nausea—Methotrexate—lung cancer	0.000668	0.000668	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—lung cancer	0.000666	0.000666	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—lung cancer	0.000644	0.000644	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—lung cancer	0.000619	0.000619	CcSEcCtD
Betahistine—Rash—Doxorubicin—lung cancer	0.000614	0.000614	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—lung cancer	0.000613	0.000613	CcSEcCtD
Betahistine—Headache—Doxorubicin—lung cancer	0.00061	0.00061	CcSEcCtD
Betahistine—Nausea—Doxorubicin—lung cancer	0.000578	0.000578	CcSEcCtD
